Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes (Acta Neuropathologica, (2023), 10.1007/s00401-023-02561-5)

Hoffmann L, Coras R, Kobow K, López-Rivera JA, Lal D, Leu C, Najm I, Nürnberg P, Herms J, Harter PN, Bien CG, Kalbhenn T, Müller M, Pieper T, Hartlieb T, Kudernatsch M, Hamer H, Brandner S, Rössler K, Blümcke I, Jabari S (2023)

Publication Type: Journal article, Erratum

Publication year: 2023

Journal

DOI: 10.1007/s00401-023-02577-x

Abstract

In the original publication, incorrect version of Fig. 3 and wrong format of Table 1 were published. Specifically, the labels in Fig. 3 were missing and columns of Table 1 were not in the right format. The correct versions of Fig. 3 and Table 1 are shown below. The original article has been corrected.

Authors with CRIS profile

Involved external institutions

Universität Bielefeld Germany (DE) Case Western Reserve University United States (USA) (US) Ludwig-Maximilians-Universität (LMU) Germany (DE) Schön Klinik Vogtareuth Germany (DE) Cleveland Clinic United States (USA) (US) Schön Kliniken Germany (DE) Cologne Center for Genomics Germany (DE)

How to cite

APA:

Hoffmann, L., Coras, R., Kobow, K., López-Rivera, J.A., Lal, D., Leu, C.,... Jabari, S. (2023). Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes (Acta Neuropathologica, (2023), 10.1007/s00401-023-02561-5). Acta Neuropathologica. https://doi.org/10.1007/s00401-023-02577-x

MLA:

Hoffmann, Lucas, et al. "Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes (Acta Neuropathologica, (2023), 10.1007/s00401-023-02561-5)." Acta Neuropathologica (2023).

BibTeX: Download